Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
July 15, 2021
Adicet Bio Announces Formation of Scientific Advisory Board
June 28, 2021
Adicet Bio Added to the Russell 2000® Index
May 18, 2021
Adicet Bio to Participate in Upcoming Investor Conferences
May 17, 2021
Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates
April 29, 2021
Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit
April 15, 2021
Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
April 13, 2021
Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research
March 11, 2021
Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
March 10, 2021
Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B Cell Non-Hodgkin's Lymphoma
March 4, 2021
Adicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Next page next ›
  • Last page last »
Displaying 71 - 80 of 110

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2023 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.